#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Turner's syndrome Eosinophilic oesophagitis Langerhans' cell histiocytosis Cardiomyopathy Marginal zone lymphoma recurrent Angelman's syndrome Neuroendocrine tumour Dementia with Lewy bodies Lennox-Gastaut syndrome Muscular dystrophy Endometrial adenocarcinoma Non-small cell lung cancer metastatic Antiphospholipid antibodies Leukocyte adhesion deficiency type I Acute lymphocytic leukaemia More trials…

    Learn about Rare Diseases

    Rhabdomyosarcoma recurrent – Diagnostics Wolfram syndrome – Basic Information Usher’s syndrome – Treatment Hereditary hypophosphataemic rickets – Life with Disease Undifferentiated sarcoma – Basic Information VEXAS syndrome – Life with Disease Langerhans’ cell histiocytosis – Life with Disease Friedreich’s ataxia – Life with Disease Rosai-Dorfman syndrome – Treatment Leiomyosarcoma metastatic – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Amikacin RPTR-1-201 Exenatide Troriluzole HSP-CAR19M Digoxin Immune Fab (Ovine) Amiodarone Hydrochloride Amiloride Hydrochloride 4-Hydroxy-N-Desmethyltamoxifen BGB-16673 Vismodegib Cedazuridine Cendakimab Tetracaine Hydrochloride Quavonlimab Goserelin Acetate Gentamicin Sulfate Atorvastatin ORX750 Cinchocaine Hydrochloride More therapies…

    Learn about Your Condition

    Irritable bowel syndrome Stevens-Johnson syndrome Laryngeal cancer Femoral neck fracture Spinal osteoarthritis Hereditary optic atrophy Double hit lymphoma Brain stem glioma Chondrosarcoma metastatic Renal cancer Neurofibrosarcoma Autoimmune haemolytic anaemia Athetosis Graft infection Tympanic membrane perforation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Bacterial Infections and Mycoses

  • Study on the Effectiveness of Co-Trimoxazole for Treating Ventilator-Associated Pneumonia in ICU Patients Compared to a Drug Combination

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Ertapenem
    • Imipenem Monohydrate
    • Temocillin
    France

  • Study on Shortening Antibiotic Treatment for Febrile Neutropenia in Hematology Patients Using Cefepime and Drug Combination

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Febrile neutropenia
    Investigated Drugs:
    • Meropenem
    • Imipenem
    • Piperacillin
    Belgium

  • Study on Clindamycin Use for Infection Prevention in Pregnant Women Undergoing Maternal or Fetal Surgery

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Clindamycin Phosphate
    Belgium

  • Study on Dobutamine and Glucose for Patients with Septic Cardiomyopathy and Low Blood Flow

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Sepsis
    Investigated Drugs:
    • Dobutamine Hydrochloride
    • Glucose Monohydrate
    France

  • Study on Dalbavancin and Rifampicin for Treating Prosthetic Joint Infections in Patients with Hip, Knee, and Shoulder Replacements

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Staphylococcal infection
    Investigated Drugs:
    • Dalbavancin
    • Rifampicin
    France

  • Study on Emapalumab for Patients with Sepsis Linked to Interferon-Gamma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Sepsis
    Investigated Drugs:
    • Emapalumab
    • Sodium Chloride
    Greece
Previous Page
1 … 45 46 47 48
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!